Genmab ADR (NASDAQ: GMAB) is -2.92% lower on its value in year-to-date trading and has touched a low of $18.64 and a high of $31.88 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GMAB stock was last observed hovering at around $21.98 in the last trading session, with the day’s loss setting it -1.72%.
Currently trading at $20.26, the stock is -8.59% and -4.68% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.58 million and changing -7.80% at the moment leaves the stock -15.66% off its SMA200. GMAB registered -31.11% loss for a year compared to 6-month loss of -26.38%.
The stock witnessed a 6.63% gain in the last 1 month and extending the period to 3 months gives it a -7.28%, and is -13.16% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.72% over the week and 2.50% over the month.
Genmab ADR (GMAB) has around 2682 employees, a market worth around $12.88B and $3.12B in sales. Current P/E ratio is 11.57 and Fwd P/E is 11.37. Profit margin for the company is 36.30%. Distance from 52-week low is 8.72% and -36.45% from its 52-week high. The company has generated returns on investments over the last 12 months (21.67%).
with sales reaching $5.18B over the same period.The EPS is expected to shrink by -13.71% this year, but quarterly earnings will post 16.43% year-over-year. Quarterly sales are estimated to grow 24.94% in year-over-year returns.
Genmab ADR (GMAB) Top Institutional Holders
The shares outstanding are 635.50M, and float is at 635.50M with Short Float at 0.26%.
The top institutional shareholder in the company is ALLIANCEBERNSTEIN L.P. with over 15.24 million shares valued at $382.93 million. The investor’s holdings represent 23.334% of the GMAB Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.08 million shares valued at $127.67 million to account for 7.78 of the shares outstanding. The other top investors are CAPITAL INTERNATIONAL INVESTORS which holds 4.23 million shares representing 6.5161% and valued at over $108.15 million, while HARDING LOEVNER LP holds 4.2657 of the shares totaling 2.77 million with a market value of $69.61 million.
Genmab ADR (GMAB) Insider Activity
#####
